Billionaire Profile
Rudolf Maag
Global Rank
#715

Image: Public domain | via Wikimedia Commons

Rudolf Maag

CEO, Stratec Medical
CH
Real-Time Net Worth
$5.57B
As of December 2025
Age
79
Source
Medical devices
Industry
healthcare
Citizenship
CH

Biography

Rudolf Maag, a Swiss entrepreneur, built a substantial fortune primarily through the medical device industry. Born in 1946, Maag earned an MBA from INSEAD in 1973, a pivotal step that launched his career. He is ranked #701 in the world today. His early career involved roles at Sandoz AG before transitioning to Straumann, where he acquired the medical device division and took it public as Stratec Medical. His most significant achievement was orchestrating the merger of Stratec with Synthes, leading to a 15% stake in the combined entity, later sold to Johnson & Johnson. Maag's net worth is estimated at $5.57 billion, and his primary source of wealth remains medical devices. His residence is in Binningen, Switzerland. He has been married and has two children. He also holds significant investments in pharmaceuticals and the luxury hospitality sector. Maag is known for his private nature, maintaining a low profile despite his business success.

Wealth Over Time

In-Depth Profile

Early Life

Rudolf Maag was born in Liestal, Switzerland, in 1946. His early life was marked by a childhood and youth spent in Liestal. A career change was triggered due to a work-related accident. He later pursued an education in business and management.

Rise to Success

Maag's career began in 1968 at the Basler Handelsgesellschaft (UTC), followed by roles at Sandoz AG in Basel. His career took a decisive turn when he recognized an opportunity in Straumann's medical device division, leading to its acquisition in 1990 and its subsequent public listing as Stratec Medical in 1996. The merger of Stratec Medical with Synthes in 1999 proved to be a turning point, yielding him a 15% stake in the merged company.

Key Business Strategies

Maag's success stems from his strategic acquisitions and mergers in the medical device sector. His ability to identify and capitalize on opportunities, particularly within the medical device industry, has been central to his wealth creation. A key strategy was recognizing the potential of Stratec Medical and later orchestrating its merger with Synthes, which was acquired by Johnson & Johnson.

Philanthropy

Maag has demonstrated philanthropic interests, notably contributing €5 million (approximately $5.9 million USD) to INSEAD in 2005, making him the institution's largest donor. Further details regarding his specific philanthropic activities are not extensively documented in the available sources, indicating a preference for privacy in this area.

Career Milestones

1973

MBA from INSEAD

Graduated with an MBA from INSEAD, setting the foundation for his career.

1990

Acquired Straumann's medical device division

Acquired the medical device division of Straumann, later forming Stratec Medical.

1999

Merger of Stratec Medical and Synthes

Orchestrated the merger of Stratec Medical with Synthes, creating a significant stake in the combined entity.

2002-2010

Chairman of Straumann Holding AG

Served as Chairman.

2005

Donation to INSEAD

Donated €5 million to INSEAD.

Philanthropy & Social Impact

Education

INSEAD Donation

$5.9M

Made a significant donation to INSEAD to benefit the Rudolf and Valeria Maag International Centre for Entrepreneurship.